Paper Review Records
All Paper Review Records
20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
41
days
First-Line Immune Checkpoint Inhibitors in Older Patients with Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis
Authors
Dalila Incognito; Andrea D’Arienzo; Sergio Facchini; Chiara Barraco; Antonio Picone; Antonella Nicastro; Giuliana Ciappina; Giordana Di Mauro; Antonio Ieni; Massimiliano Berretta; Gaetano FacchiniShow moreShow less
Affiliations
1. Medical Oncology Unit, Department of Human Pathology “G. Barresi”, School of Specialization in Medical Oncology, University of Messina, 98122 Messina, Italy; 2. Translational Molecular Medicine and Surgery, Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy; 3. Oncology Unit, “Santa Maria Delle Grazie” Hospital, 80078 Pozzuoli, Italy; 4. Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Naples, Italy; 5. Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy; 6. Section of Experimental Medicine, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy; 7. Applied Biology and Experimental Medicine, Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166 Messina, Italy; 8. Department of Human Pathology of Adult and Childhood “Gaetano Barresi”, University of Messina, 98121 Messina, Italy; 9. Division of Medical Oncology, “G. Martino” University Hospital, University of Messina, 98124 Messina, ItalyShow moreShow less
44
days
SBRT for Colorectal Cancer Liver Metastasis Is a Safe and Effective Treatment Option—A Single Institution Retrospective Analysis
Authors
Nitsan Peled Oved; Marc Wygoda; Adi Levy; Mor Oved; Philip Blumenfeld; Ayala Hubert; Aron Popovtzer; Tamar Peretz; Aviad Zick; Tal Falick MichaeliShow moreShow less
Affiliations
1. Department of Medical and Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem 91120, Israel; 2. Department of Military Medicine and “Tzamert”, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91120, Israel; 3. Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem 91120, IsraelShow moreShow less
83
days
Functionally Informed Hand Knob Reveals Structural Connectome Differences in Motor-Eloquent Tumours
Authors
Sankhya Prakashvel; Filippo Sinosi; Laura Ferrari; Feras Fayez; Sabina Patel; Yasir A. Chowdhury; Andrea Perera; Nida Kalyal; Mariam Awan; Alba Diaz-Baamonde; Ana Mirallave-Pescador; Keyoumars Ashkan; Ranjeev Bhangoo; Francesco Vergani; Jose Pedro LavradorShow moreShow less
Affiliations
1. Queens’ Hospital Romford, London RM7 0AG, UK; 2. King’s College Hospital, London SE5 9RS, UK; 3. University College London Hospital, London NW1 2BU, UKShow moreShow less
18
days
Plasma 4β-Hydroxycholesterol Predicts Ribociclib CYP3A-Mediated Metabolism, but Not Plasma Exposure, in Patients with Primary Brain Cancer
Authors
Charuka Wickramasinghe; Xun Bao; Yuanyuan Jiang; Jun Jiang; Yang Yue; Nader Sanai; Jing LiShow moreShow less
Affiliations
1. Karmanos Cancer Institute, Wayne State University School of Medicine, 4100 John R Street, HWCRC, Room 523, Detroit, MI 48201, USA; 2. Barrow Neurological Institute, St. Joseph’s Hospital & Medical Center, Phoenix, AZ 85004, USAShow moreShow less
27
days
Post-Recurrence Outcomes Associated with a Bevacizumab-Containing First-Recurrence Strategy in Glioblastoma: A Propensity-Weighted Single-Center Cohort Study with Competing-Risk Analysis
Authors
Enes Yeşilbaş; Sema Sezgin GöksuShow moreShow less
Affiliations
1. Department of Medical Oncology, Ankara Etlik City Hospital, Ankara 06010, Türkiye; 2. Department of Medical Oncology, Faculty of Medicine, Akdeniz University, Antalya 07070, TürkiyeShow moreShow less
32
days
Incorporating Metastatic Disease Burden into Prognostic Assessment in Metastatic Castration-Resistant Prostate Cancer: The MIRA Score
Authors
Mario Uccello; Panagiotis J. Vlachostergios; Aruni Ghose; Stergios BoussiosShow moreShow less
Affiliations
1. Royal United Hospitals Bath NHS Foundation Trust, Bath BA1 3NG, UK; 2. Department of Medical Oncology, IASO Thessalias Hospital, 41500 Larissa, Greece; 3. Department of Medical Oncology, Ioannina University Hospital, 45500 Ioannina, Greece; 4. Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece; 5. Division of Hematology & Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA; 6. Cancer Division, University College London Hospitals NHS Foundation Trust, London NW1 2BU, UK; 7. Department of Research and Innovation, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK; 8. School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King’s College London, London SE1 1UL, UK; 9. Faculty of Medicine, Health and Social Care, Canterbury Christ Church University, Canterbury CT1 1QU, UK; 10. AELIA Organisation, 9Th Km Thessaloniki-Thermi, 57001 Thessaloniki, GreeceShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days